Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
Clinical trial NCT04410523 · TERMINATED
Trial details
- NCT number
- NCT04410523
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2022-07-12
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.